HIGH-DOSE, 4.0 G/DAY MESALAMINE FOR PATIENTS WITH ULCERATIVE COLITIS WHO RELAPSED UNDER LOW-DOSE, 1.5-2.25 G/DAY MAINTENANCE THERAPY: SAFETY AND EFFICACY

(1) Yokkaichi Social Insurance, Hospital Inflammatory Bowel, Disease Centre, Yokkaichi, Japan

(2) Inflammatory Bowel DiseaseCentre, YOKKAICHI SOCIAL INSURANCE HOSPITAL, Yokkaichi, Japan



This item was part of the Inflammatory Bowel Disease III session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A416